Examples of 'biopharmaceutical companies' in a sentence
Meaning of "biopharmaceutical companies"
biopharmaceutical companies: These are companies that focus on developing and producing pharmaceutical drugs using biotechnological methods. They are involved in researching, testing, and manufacturing medications derived from living organisms or their byproducts
                                                                                            How to use "biopharmaceutical companies" in a sentence
                                        
                                        Basic
                                    
                                    
                                        
                                        Advanced
                                    
                                
                                
                                
                                biopharmaceutical companies
                                
                                
                                
                            
                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Innovative biopharmaceutical companies and service companies.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    The effect of technology changes on the stock market valuation of biopharmaceutical companies.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Current state of biopharmaceutical companies.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    PPA is connected to hundreds of patient assistance programs, including those offered by biopharmaceutical companies.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    He built his fortune by creating two biopharmaceutical companies and later selling them.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Biopharmaceutical companies that are the strongest performers on TSI see a 12 percent premium on their valuation.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Dompé is one of the leading biopharmaceutical companies in Italy.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    As a result, biopharmaceutical companies will switch from selling medicines to managing outcomes.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    This could all lead to potentially faster sales growth for biopharmaceutical companies in China.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    The pharmaceutical and biopharmaceutical companies to hold the largest share of the market.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Therefore today, Sanofi is one of the industry 's leading biopharmaceutical companies.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Pharmaceutical and biopharmaceutical companies are the largest end users of the filter integrity test market.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    We are proud to count some of the world 's top 10 biopharmaceutical companies among our clients.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Biopharmaceutical companies have played a key role in the fight against another deadly disease, HIV / AIDS.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    IPSOGEN is also a partner of choice for biopharmaceutical companies committed to revolutionary companion diagnostics.
                                        
                                    See also
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Smaller, lesser-known biopharmaceutical companies can offer the biggest compensation packages.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    The trial was funded by the biopharmaceutical companies NoNO and Arbor Vita.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Today, America 's biopharmaceutical companies are researching 98 medicines Embed codes at end of release.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Their expertise in building world-class biopharmaceutical companies will be invaluable as we grow the company . ”.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    NIH partners with 11 leading biopharmaceutical companies to accelerate the development of new cancer immunotherapy strategies.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    During the second quarter of 2018, global biopharmaceutical companies reported accelerating sales in China.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    The pharmaceutical & biopharmaceutical companies segment accounted for the largest market share in 2018.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    The world 's ten greatest biopharmaceutical companies all have a base in our country.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    As a consequence, startup biopharmaceutical companies on the US model do not exist in Japan.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Right now, America 's biopharmaceutical companies are working on more than 800 cancer medicines.
                                        
                                    You'll also be interested in:
                                        Examples of using Biopharmaceutical
                                        
                                                                                            
                                                    
                                                        
                                                        
                                                    
                                                        
                                                        
                                                                                                            
                                                
                                                                                            
                                                    
                                                        
                                                        
                                                    
                                                        
                                                        
                                                                                                            
                                                
                                                                                            
                                                    
                                                        
                                                        
                                                    
                                                        
                                                        
                                                                                                            
                                                
                                                                                    
                                        
                                            Show more
                                    
                                                                    
                                                            Biopharmaceutical validation of the extended release form
                                                        
                                                    
                                                            It is thus that the biopharmaceutical contents are sterilized
                                                        
                                                    
                                                            Biopharmaceutical contract manufacturing maintains lead position
                                                        
                                                    
                                        Examples of using Companies
                                        
                                                                                            
                                                    
                                                        
                                                        
                                                    
                                                        
                                                        
                                                                                                            
                                                
                                                                                            
                                                    
                                                        
                                                        
                                                    
                                                        
                                                        
                                                                                                            
                                                
                                                                                            
                                                    
                                                        
                                                        
                                                    
                                                        
                                                        
                                                                                                            
                                                
                                                                                    
                                        
                                            Show more
                                    
                                                            
                                                            Several software companies participated in its development
                                                        
                                                    
                                                            You should call your insurance companies
                                                        
                                                    
                                                            Your companies pay terrorists to make war